Cargando…

Anti-apoptotic peptide for long term cardioprotection in a mouse model of myocardial ischemia–reperfusion injury

Reperfusion therapy during myocardial infarction (MI) leads to side effects called ischemia–reperfusion (IR) injury for which no treatment exists. While most studies have targeted the intrinsic apoptotic pathway to prevent IR injury with no successful clinical translation, we evidenced recently the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Covinhes, Aurélie, Gallot, Laura, Barrère, Christian, Vincent, Anne, Sportouch, Catherine, Piot, Christophe, Lebleu, Bernard, Nargeot, Joël, Boisguérin, Prisca, Barrère-Lemaire, Stéphanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582178/ https://www.ncbi.nlm.nih.gov/pubmed/33093627 http://dx.doi.org/10.1038/s41598-020-75154-x

Ejemplares similares

Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
por: Vincent, Anne, et al.
Publicado: (2017)

Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
por: Fernandez Rico, Carlota, et al.
Publicado: (2022)

Heart rate reduction after genetic ablation of L-type Ca(v)1.3 channels induces cardioprotection against ischemia-reperfusion injury
por: Delgado-Betancourt, Viviana, et al.
Publicado: (2023)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2021)

PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
por: Barrère-Lemaire, Stéphanie, et al.
Publicado: (2022)

Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II
por: Kumphune, Sarawut, et al.
Publicado: (2023)

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2021)

Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway
por: Zeng, Cheng, et al.
Publicado: (2018)

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats
por: Sanit, Jantira, et al.
Publicado: (2019)

Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021)

Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies
por: Wohlfart, Paulus, et al.
Publicado: (2013)

Cardioprotective Effect of Betulinic Acid on Myocardial Ischemia Reperfusion Injury in Rats
por: Xia, Anzhou, et al.
Publicado: (2014)

Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
por: Liu, Nan-Bo, et al.
Publicado: (2019)

Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury
por: Prag, Hiran A., et al.
Publicado: (2022)

Isolated Mitochondria State after Myocardial Ischemia-Reperfusion Injury and Cardioprotection: Analysis by Flow Cytometry
por: Crola Da Silva, Claire, et al.
Publicado: (2023)

Cardioprotective effects of Guanxinshutong (GXST) against myocardial ischemia/ reperfusion injury in rats
por: Liang, Zhuo, et al.
Publicado: (2012)

Cardioprotective effects of sinomenine in myocardial ischemia/reperfusion injury in a rat model
por: Lu, Changhong, et al.
Publicado: (2022)

Targeting Cell Signaling and Apoptotic Pathways by Luteolin: Cardioprotective Role in Rat Cardiomyocytes Following Ischemia/Reperfusion
por: Xu, Tongda, et al.
Publicado: (2012)

Cardioprotective Effects of Salvianolic Acid A on Myocardial Ischemia-Reperfusion Injury In Vivo and In Vitro
por: Fan, Huaying, et al.
Publicado: (2012)

The Cardioprotective Effects of Citric Acid and L-Malic Acid on Myocardial Ischemia/Reperfusion Injury
por: Tang, Xilan, et al.
Publicado: (2013)

Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart
por: Qu, Daoxu, et al.
Publicado: (2016)

Cardioprotective Effect of Electroacupuncture Pretreatment on Myocardial Ischemia/Reperfusion Injury via Antiapoptotic Signaling
por: Lu, Sheng-feng, et al.
Publicado: (2016)

Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury
por: Intachai, Kannaporn, et al.
Publicado: (2018)

Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020)

Kynurenic Acid: A Novel Player in Cardioprotection against Myocardial Ischemia/Reperfusion Injuries
por: Kamel, Rima, et al.
Publicado: (2023)

Concomitant genetic ablation of L-type Ca(v)1.3 (α(1D)) and T-type Ca(v)3.1 (α(1G)) Ca(2+) channels disrupts heart automaticity
por: Baudot, Matthias, et al.
Publicado: (2020)

Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
por: Seefeldt, Jacob Marthinsen, et al.
Publicado: (2021)

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
por: Sahin, Mazlum, et al.
Publicado: (2022)

Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury
por: Lin, Duomao, et al.
Publicado: (2015)

Plumbagin Mediates Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Through Nrf-2 Signaling
por: Wang, Shi-Xun, et al.
Publicado: (2016)

ATP-induced cardioprotection against myocardial ischemia/reperfusion injury is mediated through the RISK pathway
por: Lian, Zhe-Xun, et al.
Publicado: (2016)

Cardioprotective Effect of Isosorbide Dinitrate Postconditioning Against Rat Myocardial Ischemia-Reperfusion Injury In Vivo
por: Zhao, Xinwen, et al.
Publicado: (2019)

BCL2-regulated apoptotic process in myocardial ischemia-reperfusion injury (Review)
por: Korshunova, Anna Yu., et al.
Publicado: (2021)

Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia
por: Giblett, Joel P., et al.
Publicado: (2016)

Cardioprotective Effect of Licochalcone D against Myocardial Ischemia/Reperfusion Injury in Langendorff-Perfused Rat Hearts
por: Yuan, Xuan, et al.
Publicado: (2015)

N-Acetylcysteine Restores Sevoflurane Postconditioning Cardioprotection against Myocardial Ischemia-Reperfusion Injury in Diabetic Rats
por: Lin, Jiefu, et al.
Publicado: (2016)

Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts
por: Yao, Xinhua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9u5j2m9a05p6pqgrvfvpd12i7i